Lee Gary K.
Chief Scientific Officer at LYEL
- Sold, on record
- $90k
- Dollars the filings state
- Form 4 sales
- 8
- Latest Aug 21, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- LYELLyell Immunopharma, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale LYELNo planAug 12, 2025 2025
Sold 267 shares at $10.43 ($3k)
Lee Gary K., Chief Scientific Officer
No 10b5-1 planSold 2.9% of holdings ($96k position)8,957 shares leftFirst sale on recordFiling
- 2 Form 4 sale LYELNo planAug 21, 2025 +9 days
Sold 1,453 shares at $10.54 ($15k)
Lee Gary K., Chief Scientific Officer
No 10b5-1 planSold 8.6% of holdings ($179k position)15,504 shares leftFiling
- 3 Form 4 sale LYELNo planNov 10, 2025 +81 days
Sold 138 shares at $16.16 ($2k)
Lee Gary K., Chief Scientific Officer
No 10b5-1 planSold 0.9% of holdings ($251k position)15,366 shares leftFiling
- 4 Form 4 sale LYELNo planFeb 10, 2026 +92 days
Sold 147 shares at $23.12 ($3k)
Lee Gary K., Chief Scientific Officer
No 10b5-1 planSold 0.8% of holdings ($434k position)18,609 shares left0.6x usual sizeFiling
- 5 Form 4 sale LYELUnusualFeb 11, 2026 +1 day
Sold 1,671 shares at $23.39 ($39k)
Lee Gary K., Chief Scientific Officer
No 10b5-1 planSold 9% of holdings ($435k position)16,938 shares left8.1x usual sizeFiling
- 6 Form 4 sale LYELNo planMay 11, 2026 +89 days
Sold 130 shares at $18.92 ($2k)
Lee Gary K., Chief Scientific Officer
No 10b5-1 planSold 0.7% of holdings ($339k position)17,808 shares left0.5x usual sizeFiling
- 7 Form 4 sale LYELNo planAug 10, 2026 +91 days
Sold 131 shares at $14.34 ($2k)
Lee Gary K., Chief Scientific Officer
No 10b5-1 planSold 0.7% of holdings ($255k position)17,677 shares left0.6x usual sizeFiling
- 8 Form 4 sale LYELUnusualAug 21, 2026 +11 days
Sold 1,457 shares at $15.54 ($23k)
Lee Gary K., Chief Scientific Officer
No 10b5-1 planSold 8.2% of holdings ($275k position)16,220 shares left9.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Aug 25, 2026 | LYEL | Chief Scientific Officer | Form 4 sale | 1,457 | $23k | 8.2% | Unusual | SEC |
| Aug 10, 2026 | Aug 11, 2026 | LYEL | Chief Scientific Officer | Form 4 sale | 131 | $2k | 0.7% | No plan | SEC |
| May 11, 2026 | Jun 15, 2026 | LYEL | Chief Scientific Officer | Form 4 sale | 130 | $2k | 0.7% | No plan | SEC |
| Feb 11, 2026 | Feb 12, 2026 | LYEL | Chief Scientific Officer | Form 4 sale | 1,671 | $39k | 9.0% | Unusual | SEC |
| Feb 10, 2026 | Feb 11, 2026 | LYEL | Chief Scientific Officer | Form 4 sale | 147 | $3k | 0.8% | No plan | SEC |
| Nov 10, 2025 | Nov 12, 2025 | LYEL | Chief Scientific Officer | Form 4 sale | 138 | $2k | 0.9% | No plan | SEC |
| Aug 21, 2025 | Aug 22, 2025 | LYEL | Chief Scientific Officer | Form 4 sale | 1,453 | $15k | 8.6% | No plan | SEC |
| Aug 12, 2025 | Aug 13, 2025 | LYEL | Chief Scientific Officer | Form 4 sale | 267 | $3k | 2.9% | No plan | SEC |